Clinical Trial

Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To screen ischemic stroke patients likely to benefit from anticoagulation and compare the effectiveness and safety of anticoagulation versus antiplatelet therapy in preventing recurrent ischemic stroke within 3 months.
Trial Details
NCT Number NCT07746882
Lead Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions Stroke, Acute Ischemic Stroke
Enrollment 680 participants
Start Date 2026-08-15
Primary Completion 2028-08-31 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05